Search results
Results from the WOW.Com Content Network
In April 2018, after 5 years of research, Sanjay Gupta backed medical marijuana for conditions such as epilepsy and multiple sclerosis. [19] He believes that medical marijuana is safer than opioid for pain management. [20] [21]
When usual treatments are ineffective, cannabinoids have also been recommended for anorexia, arthritis, glaucoma, [19] and migraine. [20] It is unclear whether American states might be able to mitigate the adverse effects of the opioid epidemic by prescribing medical cannabis as an alternative pain management drug. [21]
An analysis of insurance claims suggests that the legalization of medical marijuana is associated with reduced opioid dispensing and pain-related hospital visits. ... from medical marijuana for ...
Here’s where science currently stands on the use of marijuana for pain, sleep, anxiety, ... 2 Indian companies indicted in US for importing ingredients used in opioid fentanyl.
Proposition 215 – the Compassionate Use Act of 1996 – was subsequently approved with 56% of the vote, legalizing the use, possession, and cultivation of cannabis by patients with a physician's recommendation, for treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or "any other illness for which ...
The search for alternative treatments for chronic pain has begun to push the very boundary of what constitutes treatment, physician Haider Warraich writes. Opioids don’t do enough for chronic ...
The medical use of marijuana for pain relief could be safer than traditional opioids used for pain relief as marijuana cannot be overdosed on and is less addictive. Marijuana could also replace the use of common non-steroidal anti-inflammatory drugs (NSAIDs) such as Advil or Aleve that have been known to cause kidney or ulcer problems. [100]
Opioids have been described as a cost-effective treatment for chronic pain, but the impact of the opioid epidemic and deaths caused by opioid overdoses should be considered in assessing their cost-effectiveness. [198] Data from 2017 suggest that in the U.S. about 3.4 percent of the U.S. population are prescribed opioids for daily pain ...